Trimetazidine Modified Release Tablet

Trimetazidine modified release tablet has been developed to maintain a prolonged coverage in patients with ischaemic heart disease by providing sustained antianginal and anti-ischaemic efficacy round-the-clock. Trimetazidine may be used in patients with angina as add-on therapy. Trimetazidine (TMZ) is an anti-ischemic metabolic agent that has been shown to be efficacious in angina treatment, both in monotherapy and in combination. The trimetazidine modified release tablet is made for use in the treatment of various ailments. The tablet is made for medical purposes.